Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ImmunityBio (IBRX) Amortization - Intangibles: 2015-2020

Historic Amortization - Intangibles for ImmunityBio (IBRX) over the last 6 years, with Dec 2020 value amounting to -$858,000.

  • ImmunityBio's Amortization - Intangibles fell 368.75% to -$225,000 in Q2 2021 from the same period last year, while for Jun 2021 it was -$1.0 million, marking a year-over-year decrease of 1028.26%. This contributed to the annual value of -$858,000 for FY2020, which is 28700.00% down from last year.
  • ImmunityBio's Amortization - Intangibles amounted to -$858,000 in FY2020, which was down 28,700.00% from $3,000 recorded in FY2019.
  • Over the past 5 years, ImmunityBio's Amortization - Intangibles peaked at $3,000 during FY2019, and registered a low of -$2.2 million during FY2016.
  • In the last 3 years, ImmunityBio's Amortization - Intangibles had a median value of -$463,000 in 2018 and averaged -$439,333.
  • In the last 5 years, ImmunityBio's Amortization - Intangibles soared by 100.65% in 2019 and then tumbled by 28,700.00% in 2020.
  • Over the past 5 years, ImmunityBio's Amortization - Intangibles (Yearly) stood at -$2.2 million in 2016, then climbed by 26.81% to -$1.6 million in 2017, then skyrocketed by 71.01% to -$463,000 in 2018, then spiked by 100.65% to $3,000 in 2019, then tumbled by 28,700.00% to -$858,000 in 2020.